Cytel, Inc., the leading global provider of innovative analytical software and services to the life sciences industry, has partnered with New Mountain Capital, LLC, a growth-oriented investment firm. Cytel, headquartered in Cambridge, MA, is widely recognized as the industry pioneer of adaptive clinical trials and a thought-leader in statistical science. New Mountain identified Cytel through its long-standing commitment to healthcare and life sciences, with a particular focus on technology-enabled services. The deal was announced on November 1.
The Ropes & Gray team was led by mergers & acquisitions and private equity partner John Sorkin and private equity partner Garrett Charon.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find our more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.